סינגולייר 4 מ"ג גרנולות לקטנטנים

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

MONTELUKAST AS SODIUM 4 MG

Disponible desde:

MERCK SHARP & DOHME ISRAEL LTD

Código ATC:

R03DC03

formulario farmacéutico:

GRANULES

Vía de administración:

PER OS

Fabricado por:

MERCK SHARP & DOHME, NETHERLANDS

Grupo terapéutico:

MONTELUKAST

indicaciones terapéuticas:

Singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treament of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitatly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.

Fecha de autorización:

2009-01-01